Tourmaline Bio, Inc. clinical trials
Acquired by Novartis, Oct 28, 2025 · source ↗
The registry lists 2 studies whose lead sponsor is Tourmaline Bio, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 11, 2026.
- 2studies on the registry
- 0open to participants now
Before and after it joined Novartis
- First submitted before Tourmaline Bio, Inc. became part of Novartis
- 2
- First submitted after Tourmaline Bio, Inc. became part of Novartis
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Tourmaline Bio, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 2
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 224
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Tourmaline Bio, Inc., a Novartis Company2 studies
Something wrong with this grouping? Tell us on the Novartis page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Novartis studies →
- A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRPCompletedNCT06362759Phase 2
Sponsor listed in the registry: Tourmaline Bio, Inc., a Novartis Company · First submitted before Tourmaline Bio, Inc. became part of Novartis
- A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseaseActive, not recruitingNCT06088979Phase 2
Sponsor listed in the registry: Tourmaline Bio, Inc., a Novartis Company · First submitted before Tourmaline Bio, Inc. became part of Novartis